| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $4.8M | — |
| Cost of Revenue | $2.5M | +60.6% |
| Gross Profit | $2.3M | — |
| R&D Expense | $178K | -71.1% |
| SG&A Expense | $1.5M | -43.0% |
| Operating Income | -$11.6M | -251.8% |
| Pre-tax Income | -$11.6M | -2357.5% |
| Income Tax | $195K | — |
| Net Income | -$11.8M |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.0M | -47.6% |
| Accounts Receivable | $612K | +243.8% |
| Current Assets | $4.1M | -33.7% |
| Total Assets | $10.8M | +59.4% |
| Current Liabilities | $1.2M | -22.0% |
| Total Liabilities | $1.4M | -7.8% |
| Stockholders' Equity | $9.4M | +78.4% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$396K | +89.1% |
| Investing Cash Flow | $3.6M | — |
| Financing Cash Flow | -$511K | -106.1% |
| EPS (Basic) | -$0.14 | -1500.0% |